TYRO3 and hepatocellular carcinoma: Furthermore, inhibition of TYRO3 by siRNA or shRNA in hepatocellular carcinoma, CRC, and breast cancer cell lines directly reduce PI3K/AKT phosphorylation (Duan et al., 2016; Tsai et al., 2020).